Feb 13, 2026Omega-3 Fatty Acids: EPA, DHA, Cardiovascular Outcomes, and Cognitive Aging EvidenceEPA and DHA are the two clinically relevant omega-3 fatty acids. High-dose EPA (REDUCE-IT trial, 4 g/day icosapentaenoic acid) significantly reduced cardiovascular events. DHA drives brain structural benefits. Standard fish oil doses produce modest effects; high-dose prescription forms show stronger outcomes.
Feb 12, 2026Inflammation Resolution: Specialized Pro-Resolving Mediators, Omega-3 Metabolites, and Beyond SuppressionMost anti-inflammatory strategies suppress inflammation. Resolution is an active, distinct process mediated by specialized pro-resolving mediators (SPMs) — resolvins, protectins, and maresins — derived from omega-3 fatty acids. Supporting resolution rather than just suppression may be the more effective long-term approach.
Feb 4, 2026Anti-Inflammatory Supplement Comparison: Curcumin vs Boswellia vs Omega-3 vs GingerThe four most clinically studied anti-inflammatory supplements work through different molecular targets. Omega-3 resolves inflammation via resolvins and protectins. Curcumin inhibits NF-kB and COX-2. Boswellia inhibits 5-LOX. Ginger modulates multiple pathways. Combining agents may provide additive effects.
Jan 25, 2026Lipid Management: Omega-3, Red Yeast Rice Context, Plant Sterols, and Evidence ReviewNatural lipid management is most effective for triglycerides (omega-3) and LDL reduction (plant sterols, soluble fiber). Red yeast rice contains naturally occurring statins and shares their side effect profile. The evidence hierarchy matters when deciding between lifestyle, supplements, and medications.
Jan 19, 2026Cardiovascular Protection Supplement Stack: Omega-3, CoQ10, Garlic, and Cocoa FlavanolsA rational cardiovascular supplement stack addresses inflammation (omega-3), mitochondrial function (CoQ10), blood pressure and endothelial function (aged garlic, cocoa flavanols). This article maps the evidence for each component and how to prioritize them.